MASSACHUSETTS GENERAL HOSPITAL
Polyclonal Bi-Specific Vectored ImmunoTherapy to Functionally Cure HIV Infection
Polyclonal Bi-Specific Vectored ImmunoTherapy to Functionally Cure HIV Infection is a funding opportunity from MASSACHUSETTS GENERAL HOSPITAL, up to 1052100, closing March 31, 2029.
Mar 31, 2029
(974d left)Overview
Project Summary / Abstract This proposal describes the framework of a DP1 grant for Alejandro B. Balazs, PhD. Dr. Balazs is currently an assistant professor at Harvard Medical School and a principal investigator at the Ragon Institute of MGH, MIT & Harvard. Dr. Balazs' research is focused on engineering the immune…